Skip to main content
. 2021 Sep 12;13(9):e17900. doi: 10.7759/cureus.17900

Table 2. Comparison of demographic and laboratory characteristics between mortality and survival group.

PD: Peritoneal Dialysis; BMI: Body Mass Index; PET: Peritoneal Equilibration Test; H: High; HA: High-Average; LA: Low-Average; L: Low; CCr: Creatinine clearance; WBC: White Blood Cell; hs-CRP: high sensitive C Reactive Protein.

Clinical characteristics and laboratory parameters Mortality group (n=41) Survival group (n=226) p
Ages (years) 47.98 ± 12.91 49.1 ± 13.72 0.628
Number of male (n,%) 27 (65.9) 123 (54.4) 0.175
PD duration (month) 24 (15.5 – 43.5) 19 (9 – 39.25) 0.22
Hypertension (n,%) 30 (73.2) 192 (85) 0.064
Diabetic mellitus (n,%) 17 (41.5) 26 (11.5) < 0.001
BMI (kg/m2) 22.33 ± 3.78 21 ± 2.74 0.038
BMI < 18.5 5 (12.2) 39 (17.3) 0.04
BMI: 18.5 – 22.9 20 (48.8) 140 (61.9)
BMI ≥ 23 16 (39) 47 (20.8)
24-hour urine volume (ml) 165 (117.5 – 600) 180 (130 – 500) 0.681
Residual kidney function 12 (29.3) 63 (27.9) 0.855
D4/P 0.71 (0.62 – 0.75) 0.73 (0.62 – 0.77) 0.187
PET H (n,%) 3 (7.3) 17 (7.5) 0.529
PET HA (n,%) 22 (53.7) 144 (63.7)
PET LA (n,%) 15 (36.6) 63 (27.9)
PET L (n,%) 1 (2.4) 2 (0.9)
Serum urea (mmol/L) 21.62 ± 5.13 18.93 ± 6.23 0.01
Creatinine (µmol/L) 831.9 (699.15 – 982.35) 761.1 (643.61 – 955.8) 0.226
Kt/V 1.95 ± 0.33 1.99 ± 0.3 0.47
Total CCr (L/week/1.73m2) 61.45 ± 11.29 62.81 ± 8.93 0.393
Hemoglobin (g/L) 104.16 ± 12.5 99.41 ± 17.63 0.1
Anemia (n,%) 40 (97.6) 215 (95.1) 0.49
WBC (G/L) 7.03 ± 1.56 6.85 ± 1.48 0.472
Neutrophil (%) 61.1 ± 10.4 61.4 ± 8.16 0.836
Glucose (mmol/L) 4.22 (3.75 – 4.75) 4.19 (3.81 – 4.84) 0.898
Na+ (mmol/L) 137.09 ± 3.44 136.89 ± 3.8 0.745
K+ (mmol/L) 3.87 ± 0.78 3.64 ± 0.78 0.094
Ca++ (mmol/L) 2.09 ± 0.36 2.04 ± 0.29 0.372
Protein (g/dL) 6.59 ± 0.88 6.5 ± 0.66 0.448
Albumin (g/dL) 3.77 ± 0.45 3.67 ± 0.49 0.222
Prealbumin (mg/dL) 0.3 ± 0.07 0.34 ± 0.08 0.005
Uric acid (µmol/L) 502.7 ± 105.63 399.28 ± 69.02 < 0.001
Increase uric acid (n,%) 35 (85.4) 121 (53.5) < 0.001
hs-CRP (mg/L) 5.1 (3.1 – 5.65) 2 (1 – 3.6) < 0.001
Increase hs-CRP (n,%) 21 (51.2) 12 (5.3) < 0.001